AMENDMENT NO. 1 TO THE CO-PROMOTION AGREEMENTCo-Promotion Agreement • August 1st, 2013 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 1 (this “Amendment”) is made as of July 31, 2013 (the “Amendment No. 1 Effective Date”) by and among GlaxoSmithKline LLC, a Delaware limited liability company (“GSK”) and Auxilium Pharmaceuticals, Inc., a Delaware corporation (“Auxilium”). GSK and Auxilium are sometimes referred to herein individually as a “Party” and collectively as the “Parties”.
COLLABORATION AGREEMENT DATED AS OF JULY 15, 2013 BY AND AMONG AUXILIUM UK LTD AND AUXILIUM INTERNATIONAL HOLDINGS, INC. AND SWEDISH ORPHAN BIOVITRUM AB (publ)Collaboration Agreement • August 1st, 2013 • Auxilium Pharmaceuticals Inc • Pharmaceutical preparations • New York
This Collaboration Agreement (this “Agreement”), dated as of July 15, 2013 (the “Effective Date”), is made by and among AUXILIUM UK LTD, a United Kingdom limited company, jointly and severally with Auxilium International Holdings, Inc., a Delaware corporation, (together referred to as “Auxilium”), and Swedish Orphan Biovitrum AB (publ), a Swedish corporation (“Sobi”). Auxilium and Sobi are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
